Sygnature Discovery accelerates global growth with major North American acquisition
Sygnature Discovery
JULY 31, 2023
Leading integrated drug discovery partner, Sygnature Discovery (“Sygnature”) has announced its acquisition of one of North America’s largest discovery Contract Research Organisations, Canada-based NuChem Sciences. Its staff of over 1,000, which includes 900 scientists, partners with global pharma, biotech and NFP organisations.
Let's personalize your content